Sorafenib inhibits growth migration and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis

Thursday, November 29, 2012
Ectopic endometrial mesenchymal stem cells (MSC) show increased proliferation, migration, vascular endothelial growth factor release, and HIF-1a expression in respect to eutopic or control MSC. Sorafenib inhibits both functional properties and angiogenic phenotype.

Read More

Endometrial reconstruction from stem cells

Thursday, June 28, 2012
Adult stem cells have been identified in human endometrium. Their ability to reconstruct endometrial tissue when transplanted into immunocompromised animals suggests their potential use for treating disorders associated with inadequate endometrium.

Read More

Translate »